Skip to content

    Recently Viewed


      A photo of a scientist in a lab

      Johnson & Johnson moves up eight spots on the Gartner Top 25 Supply Chain Index

      The company’s supply chain division is honored by a leading research and advisory firm for setting the standard in healthcare, and transforming customer experience.

      Share Article
      share to

      Johnson & Johnson’s supply chain marked another step on its journey to build the best supply chain in the world: It scored its highest-ever ranking on the most widely-recognized list of top performers.
      On May 25, Gartner announced its annual Top 25 Supply Chain Index. Johnson & Johnson ranked #13, moving up eight spots from its 2016 ranking. Not only was this the biggest leap forward of any company on the list, but Johnson & Johnson is now the only healthcare supply chain included on this prominent cross-industry ranking of large cap company supply chains.

      Top 25 Supply Chain Announcement

      This year’s Gartner rankings

      Gartner, a leading research and advisory firm in the supply chain and information technology space, noted Johnson & Johnson’s steady improvement in delivering high-quality metrics, customer satisfaction and cost efficiencies.

      The selection committee also called attention to the way Johnson & Johnson’s supply chain has leveraged technology to drive innovation, while continuing to enhance its environmental sustainability and corporate social responsibility.

      “This latest ranking is a strong testament to the great work done by all of our supply chain associates around the world every day to meet the needs of the customers, patients and consumers we are privileged to serve,” says Kathy Wengel, Chief Supply Chain Officer for Johnson & Johnson. “It’s exciting and very motivating for all of us at Johnson & Johnson to be ranked so highly among companies that are known for supply chain excellence. We will keep pushing ourselves to continually set the new standard in healthcare as we transform the customer experience and advance our operational capabilities to strengthen our competitive edge.”

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.